Previous reports suggest that SARS-CoV-2 infection senses NRLP3 [11,13] and that increased levels of IL-1β and IL-18 in plasma correlate with disease severity and mortality in patients with COVID-19 [35]. This evidence concerns the gene IL18 and COVID-19.